| Rofecoxib, MK0966 | |
| rofecoxib | |
| Merck & Co., Inc. | |
| MRK | |
| Oui | |
| Withdrawn from Market | |
| Small Molecule | |
| Cyclooxygenase 2 (COX2) / Prostaglandin-Endoperoxide Synthase 2 (PTGS2) | |
| New Molecular Entity (NME) | |
| Oral (PO) |
Fiche créée le 23/02/2016 par 
Guillaume vue 7 fois.